Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic
The novel coronavirus 2019 (COVID-19) and the subsequent pandemic present a challenge to neurologists treating patients with multiple sclerosis (MS) worldwide. Many national professional bodies have responded rapidly by issuing guidelines for the COVID-19 pandemic, primarily focused on MS disease-m...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Vilnius University Press
2020-06-01
|
| Rangatū: | Neurologijos seminarai |
| Ngā marau: | |
| Urunga tuihono: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27741 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|